By Marjoleine Kars A new book by the journalist Katherine Stewart finds a far-right movement seething in resentment, suspicious of reason and determined to dominate at all costs. Paul Fussell’s ...

By Nicolas Niarchos A new book by the journalist Katherine Stewart finds a far-right movement seething in resentment, suspicious of reason and determined to dominate at all costs. By Jennifer ...

Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) had soared by 15.8% as of 12:06 p.m. ET on Friday. Did the clinical-stage biotech company report great news? Nope. Instead, the stock's gains ...

In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against the other stocks. The stock market may have registered losses on Friday ...

In this week’s edition of InnovationRx, we look at a new biotech fund spearheaded by Recursion, a shift in bird flu strategy from the Trump Administration, a new vaccine approval from the FDA ...

In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes through) become one company, combining Recursion’s expertise in biology with Exscientia’s focus on chemistry.

Altitude Labs, a biotechnology accelerator backed by Recursion Pharmaceuticals, on Wednesday said it is launching a new fund to give pre-seed grants to life sciences researchers and startups disrupted ...

Hogarth signs a debut novel by Woody Brown, the first nonspeaking graduate of UCLA, and Atria takes a steamy sports romance trilogy by Melanie Iglesias Perez.

Chris Gibson, CEO of Recursion Pharmaceuticals, is investing $1 million of his own money into Altitude Lab’s pre-seed venture, which aims to support new companies in the space. Altitude Lab, which is ...